Plasma levels of atrial natriuretic peptide in patients with liver cirrhosis and its relation to ascites and renal function

Epstein M: Renal sodium handling in cirrhosis. In: Epstein M, ed. The Kidney in Liver Disease. 2nd ed, Elsevier Science, New York. 1983;25–53

Buckalew VMJr, Gruber KA: Natriuretic hormone. In: Epstein M, ed. The Kidney in Liver disease. 2nd ed, Elsevier Science, New York 1983;479–499

De Bold AJ, Borenstein HB, Veress AT, et al: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28: 89–94

Flynn TG, de Bold ML, de Bold AJ: The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983;117: 859–865

Currie MG, Geller DM, Cole BR, et al: Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria. Science 1983;221: 71–73

Sagnella GA, MacGregor GA: Cardiac peptides and the control of sodium excretion. Nature 1984;309: 666–667

Kangawa K, Matsuo H: Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commun 1984;118: 131–139

Sonnenberg H: Atrial natriuretic factor — A new hormone affecting kidney function. Klin Wochenschr 1985;63: 886–890

Shenker Y, Sider RS, Ostafin EA, et al: Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985;76: 1684–1687

Sagnella GA, Markandu ND, Shore AC, et al: Effects of changes in dietary sodium intake and saline infusion on immuno-reactive atrial natriuretic peptide in human plasma. Lancet 1985;II: 1208–1211

Naruse M, Naruse K, Obana K, et al: Immunoreactive α-human atrial natriuretic polypeptide in human plasma. Peptides 1986;7: 141–145

Campbell RC: Statistics for Biologists. 2nd ed. Cambridge University Press, Cambridge 1974

Laragh JH: Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 1985;313: 1330–1340

Wakitani K, Cole BR, Geller DM, et al: Atriopeptins: correlation between renal vasodilation and natriuresis. Am J Physiol 1985;249: F49-F53

Huang CL, Lewicki J, Johnson LK, et al: Renal mechanism of action of rat atrial natriuretic factor. J Clin Invest 1985;75: 769–773

Yamaji T, Ishibashi M, Takaku F: Atrial natriuretic factor in human blood. J Clin Invest 1985;76: 1705–1709

Arendt RM, Gerbes AL, Ritter D, et al: Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. J Hypertens 1986;4 [Suppl 2]: S131-S135

Maack T, Marion DN, Camargo MJF, et al: Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984;77: 1069–1075

Yukimura T, Ito K, Takenaga T, et al: Renal effects of a synthetic α-human atrial natriuretic polypeptide (α-hANP) in anesthetized dogs. Eur J Pharmacol 1984;103: 363–366

Beasley D, Malvin RL: Atrial extracts increase glomerular filtration rate in vivo. Am J Physiol 1985;248: F24-F30

Tikkanen I, Fyhrquist F, Metsarinne K, et al: Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet 1985;II: 66–69

McKenna TJ, Island DP, Nicholson WE, et al: The effects of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa. Endocrinology 1978, 103: 1411–1416

Brunner HR, Bear L, Sealey JE, et al: The influence of pottasium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest 1970;49: 2128–2138